Pierre Beauparlant
InvestorVenture Partner at Sanderling Ventures
About
Beauparlant, a Ph.D. with over 25 years in large pharma and venture-backed biopharma from discovery to commercialization, has served as CEO of Sanderling portfolio companies including PreciThera and SpecificiT Pharma.
Colleagues at Sanderling Ventures
Benjamin F. McGraw III
Venture Partner at Sanderling Ventures
Fred Middleton
Managing Director at Sanderling Ventures
Michael Dixon
Principal at Sanderling Ventures
Paulette Taylor
General Counsel & Principal at Sanderling Ventures
Peter McWilliams
Venture Partner at Sanderling Ventures
Robert G. McNeil
Founding Partner at Sanderling Ventures
Timothy Mills
Managing Director at Sanderling Ventures
Frequently asked questions
- Who is Pierre Beauparlant?
- Beauparlant, a Ph.D. with over 25 years in large pharma and venture-backed biopharma from discovery to commercialization, has served as CEO of Sanderling portfolio companies including PreciThera and SpecificiT Pharma.
- Where does Pierre Beauparlant work?
- Pierre Beauparlant is Venture Partner at Sanderling Ventures.